US 10253294
Galactose oxidase treatment of dendritic cells to improve their immunogenicity
granted A61KA61K2239/31A61K40/19
Quick answer
US patent 10253294 (Galactose oxidase treatment of dendritic cells to improve their immunogenicity) held by Julius-Maximilians-Universitat Wurzburg expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Julius-Maximilians-Universitat Wurzburg
- Grant date
- Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2239/31, A61K40/19, A61K40/24, A61K40/42